Drug
Odetiglucan
Odetiglucan: highest development phase Phase 1, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| odetiglucan NCT05484011 | Phase 1 | Metastatic Pancreatic Adenocarcinoma |
Latest
No recent events.
Follow Odetiglucan on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.